Opioid Use Disorder
70-84% of pregnant women with OUD do not receive
a post-partum visit in PA
Kelley, D, 2018 CMS Quality Conference
  • Increase the percentage of pregnant women screened for substance use disorders (SUD) with a validated tool
  • Increase the percentage of women with OUD who use Medication-Assisted Treatment (MAT) or are referred to MAT during pregnancy
  • Increase percentage of pregnant women with OUD who receive prenatal and postpartum care

PA Health Care Cost Containment Council
Key Interventions
  • Educating staff and patients about substance use disorders
  • Screening pregnant women for substance misuse using validated screens
  • Assisting in linking women to treatment and supportive resources
  • Encouraging skin-to-skin contact between the mother and opioid-exposed newborn
  • Providing postpartum contraceptive options prior to discharge
  • Establishing prenatal, intrapartum, and postpartum care pathways for women with OUD that incorporate care coordination among multiple providers